The mission of Image X is to improve lives by inventing and advancing new ways to image and treat disease. We focus on developing and improving anatomic and physiologic cancer imaging methods and integrating these innovations into adaptive medical therapeutic systems, particularly radiation therapy.
A critical step in applying our technology is the translation of our technology through clinical trials. We are involved in clinical trials where Prof Keall, ACRF Image X Institute members and the University of Sydney may hold patents and other intellectual property and may benefit financially from the results of the trials.
We also partner in clinical trials with external companies, including start-ups from our laboratory, in trials where we may benefit financially from the results of the trials. ACRF Image X Institute members work with the University to identify and best manage these conflicts.
Professor Paul Keall
Licenses and Assignments
A CT ventilation patent and related IP have been licensed.
Ardos has been assigned image-guided radiation therapy intellectual property.
Leo Cancer Care has licensed and been assigned image-guided radiation therapy methods.
PWR Healthcare has been assigned image-guided radiation therapy intellectual property.
Opus Medical has licensed an audiovisual biofeedback patent.
SeeTreat has been assigned image-guided radiotherapy methods from the University of Sydney.
Standard Imaging has licensed a motion platform design from Virginia Commonwealth University.
Varian has licensed image-guided radiotherapy methods from Stanford University.
Siemens for four-dimensional imaging research.
Founder of Leo Cancer Care, a company developing a real-time image-guided cancer radiotherapy system.
Founder, 20% shareholder and director of Opus Medical Pty Ltd, a company advancing the Breathe Well audiovisual biofeedback device.
Founder, 50% shareholder and director of SeeTreat Pty Ltd, a company that is advancing image guided cancer radiotherapy.
Professor Ricky O’Brien
Siemens (Principal Investigator with Paul Keall) on four-dimensional imaging research.
Founder, 5% shareholder and hardware and software developer for Opus Medical Pty Ltd, a company advancing the Breathe Well audiovisual biofeedback device.
Founder, 100% shareholder and director of PWR Healthcare Pty Ltd, a company empowering healthcare professionals with AI.
Inventor on patents and patent applications.